Introduction {#s0010}
============

Proteases constitute approximately 2% of the human proteome and are critically important for numerous biological processes such as blood coagulation, cell death, tissue morphogenesis, inflammation, and wound healing. Proteases are ubiquitously expressed and can be found secreted into the extracellular environment, anchored to the cell surface, in the cell cytosol or compartmentalized in cellular organelles such as lysosomes. Through cleavage of specific peptide bonds in proteins that are recognized as substrates, proteases mediate many cellular functions including protein degradation, enzymatic activation, and induction of cellular signaling (reviewed in [@bib81]). Serine proteases are one of the largest families of proteolytic enzymes, constituting over one third of all proteolytic enzymes, and are known to play critical roles in diverse biological functions including blood coagulation, digestion and tissue homeostasis. Serine proteases are defined by the classical histidine, aspartate, and serine amino acid residues which form their catalytic triad, that mediate the process of peptide hydrolysis. Peptide hydrolysis occurs when the nucleophilic serine residue in the enzyme's active site attacks the carbonyl moiety of the substrate peptide bond, forming an acyl intermediate, and proteolysis follows which also depends upon the histidine and aspartate residues of the enzyme ([@bib39], [@bib105]). The S1A subfamily of serine proteases are the most widely studied group of serine proteases; the protypical members being trypsin, chymotrypsin and thrombin, which are produced as soluble proteases that are secreted into the extracellular environment. In recent years, a unique sub-group of S1A serine proteases has been identified which are found to be directly anchored to the cell surface. This review focuses on the current knowledge and *in vivo* functions of this family of membrane-anchored serine proteases. Further information on this family of proteases can be found in the following comprehensive reviews: [@bib3], [@bib12], [@bib45], [@bib94], [@bib117].

Membrane-Anchored Serine Proteases {#s0015}
==================================

To date, 20 human and 22 mouse membrane-anchored serine proteases have been identified, which are classified into 3 subclasses based on the manner in which they are anchored to the cell surface ([Figure 1](#f0010){ref-type="fig"} ). These proteases are anchored to the plasma membrane either via a C-terminal glycosylphosphatidylinositol (GPI) linkage (GPI-anchored), a C-terminal transmembrane domain (Type I), or an N-terminal transmembrane domain (Type II). In addition to the extracellular serine protease domain which mediates catalytic activity, the type II transmembrane serine proteases (TTSPs), possess a stem region composed of various combinations of different accessory domains localized adjacent to the cell surface and C-terminal to the serine protease domain ([Figure 1](#f0010){ref-type="fig"}; [@bib3]; [@bib12]; [@bib94]).Figure 1The membrane-anchored serine protease family. The human GPI-anchored serine proteases are prostasin and testisin. Tryptase γ1 is the only known human type I transmembrane serine protease. The type II transmembrane serine proteases (TTSP) may be divided into four subfamilies: (1) the human airway trypsin-like protease/differentially expressed in squamous cell carcinoma (HAT/DESC) subfamily for which the stem regions are all composed of a single SEA-domain, (2) the hepsin/transmembrane protease, serine (TMPRSS) subfamily, each of which have a group A scavenger receptor domain (SRCR) in their stem region, that may be preceded by a single LDL receptor class A-like (LDLRA) domain or in enteropeptidase, an array of SEA, LDLRA, CUB, and MAM domains, (3) the matriptase subfamily, each containing a SEA-domain, two CUB domains, and 3-4 LDLRA domains in their stem region. Polyserase-1 comprises two active, and one catalytically inactive serine protease domains and a stem region containing an LDLRA domain, and (4) the corin subfamily, consisting of a single member, corin, which possesses a complex stem region composed of two frizzled domains, eight LDLRA domains, and one SRCR domain. NH~2~ indicates amino terminus and C indicates carboxyl terminus.Adapted from Antalis, T.M., Buzza, M.S., Hodge, K.M., Hooper, J.D., Netzel-Arnett, S., 2010. The cutting edge membrane-anchored serine protease activities in the pericellular microenvironment. Biochemical Journal 428 (3), 325--346 and Bugge, T.H., Antalis, T.M., Wu, Q., 2009. Type II transmembrane serine proteases. Journal of Biological Chemistry 284 (35), 23177--23181.

Catalytic Activity {#s0020}
------------------

The catalytic serine protease domains (SPD) are highly homologous, and are 225--230 amino acids in size. Being trypsin-like serine proteases, the membrane-anchored serine proteases all prefer to cleave peptide substrates after the basic amino acids arginine or lysine, and specificity is also influenced by the residues N- and C-terminal to the cleavage site. A comprehensive list of protein and peptide substrates cleaved by the membrane-anchored serine proteases *in vitro* is found in [@bib3]. Like other serine proteases, membrane-anchored serine proteases are synthesized as inactive pro-enzymes called zymogens. Proteolytic cleavage of the short N-terminal pro-peptide of the SPD is required to induce a conformationally active protease, with the cleaved pro-domain remaining attached to the protease domain by a disulfide linkage. This activation-inducing cleavage may be mediated by other serine proteases (membrane-anchored or soluble), that recognize the zymogen activation sequence of the protease as a substrate. An example of such a zymogen activation cascade is the activation of the GPI-anchored protease prostasin by the TTSP matriptase in skin ([@bib93]). Once activated, several membrane-anchored-serine proteases can also induce zymogen activation of serine proteases of the digestive, coagulation, and fibrinolytic systems (reviewed in [@bib3]). In addition, several of the TTSPs are thought to be capable of auto-activation ([@bib97], [@bib133]). In these cases the amino acid sequence of zymogen activation site of the protease resembles the substrate specificity of the protease, and pro-domain cleavage is thought to occur due to a low level of catalytic activity of the protease zymogen.

Stem Region Accessory Domains {#s0025}
-----------------------------

While the functions of the modular domains found in the stem regions of TTSPs are mostly uncharacterized, they are thought to contribute to the cell surface localization, substrate recognition or activation of the protease. Specific mutations in these domains have been described to occur in human diseases ([@bib3]). The sea urchin sperm protein (SEA)-domain appears to be important for inducing protease activation in matriptase and matriptase-2, and undergoes a spontaneous conformational non-enzymatic cleavage event required for protease activity ([@bib97], [@bib104]). In addition, the low density lipoprotein-receptor class A-like (LDLRA) domain of matriptase-2 appears important for cell surface expression ([@bib114]), and the frizzled and LDLRA domains of corin are important for macromolecular substrate recognition ([@bib62]).

Inhibition {#s0030}
----------

After activation, the protease activity of membrane-anchored serine proteases can be regulated by interactions with endogenous protease inhibitors including membrane-anchored Kunitz-type inhibitors which form a reversible inhibitory complex with the protease. The Kunitz-type inhibitors HAI-1/SPINT1 and HAI-2/SPINT2 have been shown to regulate the activity of both matriptase and prostasin *in vivo* in murine models ([@bib120], [@bib118], [@bib119], [@bib123]). *In vitro*, the protease activities of several membrane-anchored serine proteases can also be inhibited by various members of the serpin superfamily, which form irreversible covalent complexes with serine proteases (reviewed in [@bib3]). Inhibitory complexes between matriptase and anti-thrombin III (serpinC1), α1-proteinase inhibitor (serpinA1) and α2-antiplasmin (serpinF2) have been detected in breast milk, suggesting an inhibitory role for these serpins *in vivo* ([@bib130]).

While there is still much to learn about the physiological functions of individual members of this family, the development of murine models that are deficient in these proteases, and human diseases where expression or activity is reduced, have provided valuable evidence for the critical importance of many of these proteases in key biological functions as described below, and summarized in [Table 1](#t0010){ref-type="table"}, [Table 2](#t0015){ref-type="table"} .Table 1Membrane-anchored serine proteases -- physiological functions learnt through protease deficiencyProteaseFunctionImplicated substrateReferencesGPI-anchored ProstasinMaintenance of epidermal barrier functionUnknown([@bib31], [@bib72], [@bib100])Regulation of ENaC-mediated fluid clearance in lung and colon epitheliumENaC-γ subunit([@bib31], [@bib84], [@bib101])Regulation of hepatic insulin sensitivity by cleavage and inactivation of TLR-4Toll-like receptor-4 (TLR-4)([@bib132]) TestisinInvolved in sperm cell maturation and fertilizing abilityUnknown([@bib1], [@bib50], [@bib91], [@bib145])  Type II*HAT/DESC subfamily* HATUnknown. Not required for development, long-term health or survival in miceUnknown([@bib10], [@bib51], [@bib125], [@bib144]) HATL-1Unknown. Not required for development, long-term health or survival in miceUnknown([@bib27], [@bib54], [@bib108])*Hepsin/TMPRSS subfamily* HepsinImportant for hearing in mice, where it has a role in cochlear development in inner earUnknown([@bib27], [@bib35], [@bib66], [@bib131])Maintenance of liver structural homeostasis in micePro-HGF([@bib48]) TMPRSS2Unknown. Not required for development, long-term health, fertility or survival in miceUnknown([@bib27], [@bib53], [@bib58]) TMPRSS3Mediates normal hearing in humans. Shown to be critical for cochlear hair cell survival in murine model of deficiencyUnknown([@bib28], [@bib34], [@bib68], [@bib89]) TMPRSS5Mediates normal hearing in humansUnknown([@bib34], [@bib143]) EnteropeptidaseCritical for digestion of dietary proteins. Initiates a proteolytic cascade that results in the activation of several intestinal proteasesTrypsinogen([@bib38], [@bib154])*Matriptase subfamily* MatriptaseGlobal role in maintenance of epidermal and epithelial barrier function and homeostasis.Unknown([@bib75], [@bib77], [@bib149]) Matriptase-2Essential regulator of iron homeostasis that prevents iron deficiency anemiaHemojuvelin([@bib26], [@bib30], [@bib129])*Corin subfamily* CorinRegulates systemic salt and water balance to prevent hypertension and cardiac hypertrophyPro-ANP, pro-BNP([@bib20], [@bib103], [@bib135])Table 2Membrane-anchored serine proteases -- roles in human diseaseProteaseAbnormalityRole in diseaseReferencesProstasinOver-expressed in lung epithelium of cystic fibrosis patientsMay contribute to pathogenesis of cystic fibrosis by increasing fluid clearance([@bib90], [@bib101])Increased soluble prostasin detect in urine in hypertensive patientsMay have a role in development of high blood pressure([@bib83], [@bib155])Over-activity in colonic epithelium caused by loss of inhibitor functionImplicated role in fluid secretion in congenital sodium diarrhea([@bib27])TestisinAberrant expression in advanced stage ovarian cancerMay promote tumor growth and metastasis([@bib113], [@bib127])Lost in male germ cell tumorsUnknown([@bib55])HATIncreased expression and shedding into airway fluidsOccurs in patients with inflammatory airway diseases such as asthma, function is unknown([@bib148])DESC1Lost in head and neck squamous cell carcinomaUnknown([@bib67], [@bib111])HATL-5Significantly decreased in cervical, esophageal, and head and neck carcinomasUnknown([@bib87])HepsinIncreased expression in human prostate cancers which correlates with disease severityIncreases prostate cancer progression and metastasis in mouse models([@bib141])TMPRSS2Frequent gene fusions between the promotor of TMPRSS2 and the ERG protooncogene and related transcription factors in prostate cancersAndrogen responsive elements in TMPRSS2 promotor drive expression of ERG transcription factor to promote prostate cancer progression([@bib128], [@bib151])TMPRSS3Point mutations that inhibit TMPRSS3 auto-activation blocking its activityCauses non-syndromic autosomal recessive deafness([@bib71], [@bib110], [@bib136])TMPRSS4Over-expressed in epithelial carcinomas of diverse originsMay have a role in tumor progression([@bib22])TMPRSS5Point mutation that inactivates TMPRSS5Associated with human deafness([@bib34])EnteropeptidaseIntestinal deficiency caused by point mutationsFailure to thrive due to reduced digestive function([@bib42])MatriptaseMutations resulting in an inactive proteaseARIH, a rare human skin disease with ichthyosis and hair follicle defects([@bib4], [@bib6], [@bib24], [@bib69])Expression downregulated in inflammatory bowel diseasesMay contribute to loss of intestinal barrier function and disease pathogenesis([@bib64], [@bib92])Reduced expression in salivary gland epitheliumCauses loss of secretory cell function, contribute to pathogenesis of Sjogren\'s syndrome([@bib149])Over-expressed in epithelial carcinomas of diverse originsPossible role in tumor progression([@bib73])Matriptase-2Mutations that affect protease expression and activationCausal factor in familial iron-refractory iron deficiency anemia([@bib29], [@bib33], [@bib86])CorinPolymorphisms that cause reduced protease activity due to decreased zymogen activationAssociated with hypertension and cardiac hypertrophy, worse clinical outcome in patients with heart failure([@bib25], [@bib102], [@bib103], [@bib135])Mutations and reduced expression and in pregnant uterusMay have causal role in the development of pre-eclampsia([@bib23])

The GPI-Anchored Serine Proteases {#s0035}
=================================

The two human GPI--anchored-membrane-anchored serine proteases, prostasin and testisin, are structurally the most simple of this family, being composed solely of an N-terminal SPD, that is linked to the cell surface through a GPI moiety that is added to the C-terminus post-transcriptionally ([@bib21], [@bib46]; [Figure 1](#f0010){ref-type="fig"}). This lipid anchor is known to compartmentalize these proteases to specialized cholesterol-rich microdomains of the plasma membrane known as lipid rafts ([@bib43], [@bib134]). Prostasin, also known as PRSS8 and channel activating protease (CAP)-1, is found ubiquitously expressed in all epithelia ([@bib76]). In polarized epithelia such as the gastrointestinal tract and kidney, it specifically localizes to the apical (luminal) membrane ([@bib112], [@bib116], [@bib134]). Soluble forms of prostasin have been identified in both human seminal fluid and urine ([@bib63], [@bib152]), with release from the cell surface shown to be mediated by endogenous phospholipases or by proteolytic shedding ([@bib52], [@bib134]). Functionally, prostasin was the first identified membrane-anchored serine protease shown to enhance the activity of epithelial sodium channels (ENaC) by cleavage of the ENaCγ subunit to release an inhibitory peptide ([@bib11], [@bib18]). ENaC activity is important for regulating sodium and water flux across polarized epithelium, and *in vivo*, increased expression or activity of prostasin, and the associated induction of ENaC activation, may be pathologically significant in increased fluid secretion in cystic fibrosis, high blood pressure and congenial sodium diarrhea ([Table 2](#t0015){ref-type="table"}).

In mice, genetic deficiency of prostasin in the skin leads to complete loss of skin barrier function, which appears to be unrelated to defective ENaC activation ([@bib31], [@bib72], [@bib100]). The identification of prostasin\'s substrate in the epidermis remains uncertain, however, since genetic deficiency of the type II membrane-anchored serine protease matriptase results in an identical epidermal defect ([@bib75]), it is thought that these proteases participate in a zymogen activation cascade that mediates epidermal barrier function. This is also supported by *in vitro* studies showing that expression of either protease is able to induce the activation of the other ([@bib13], [@bib93]). Interestingly, one study using murine models suggests that prostasin may mediate skin barrier function by a mechanism that is independent of its catalytic activity ([@bib100]). Using a murine model of prostasin deficiency in the liver, Uchimura *et al.* found that prostasin regulates hepatic insulin signaling by the cleavage and inactivation of the cell surface toll-like receptor, TLR-4, which suppresses inflammatory signaling ([@bib132]).

Testisin (also known as ESP-1 and PRSS21), in contrast to prostasin, exhibits an extremely specific and restricted tissue distribution, being abundantly expressed solely in male germ cells and spermatocytes, with lower expression also identified in microvascular endothelial cells, and eosinophils ([@bib1], [@bib50], [@bib145]). Functionally testisin is important for sperm cell maturation and fertilizing ability in mice ([@bib91], [@bib145]), although the physiological substrate that mediates this activity is unknown. Pathologically, the aberrant testisin expression found in lung cancers and advanced ovarian cancers may contribute to tumour progression ([@bib113], [@bib127]), and the consequences of its loss in male germ cell tumors remains to be determined.

The Type I Transmembrane Serine Proteases {#s0040}
=========================================

Tryptase γ1 (also known as PRSS31, transmembrane tryptase and transmembrane protease γ-1) is found only in hematopoietic cells and is stored as the major component of mast cell secretory granules ([@bib19], [@bib139], [@bib138]). Upon mast cell degranulation, tryptase γ1 is retained on the cell surface by its N-terminal transmembrane domain ([@bib137]). The physiological function and substrates of tryptase γ1 remain unknown, but it is speculated that it may play a role in pathogen host defense in the human airway, where mast cells are important for protection against bacterial infections ([@bib137]). In an animal model of exogenous administration to the airway, tryptase γ1 promoted airway hyperresponsiveness and induced the expression of interleukin-13 (IL-13) in bronchiolar lavage fluid ([@bib137]), which is a key cytokine implicated in the pathogenesis of allergic asthma.

The Type II Transmembrane Serine Proteases {#s0045}
==========================================

TTSPs are by far the largest group of membrane-anchored serine proteases, with 17 members in humans and 19 members in mice ([@bib12], [@bib124]; [Figure 1](#f0010){ref-type="fig"}). All are anchored to the cell surface by a C-terminal transmembrane domain, and have been phylogenetically divided into 4 subfamilies: (1) the human airway trypsin-like (HAT)/differentially expressed in squamous cell carcinoma gene (DESC) subfamily, (2) the hepsin/transmembrane protease, serine (TMPRSS) subfamily, (3) the matriptase subfamily, and (4) the corin subfamily. In comparison to the GPI-anchored and type I serine proteases, which are composed of essentially a SPD and membrane anchor, the TTSPs possess a stem region C-terminal to the protease domain, which is comprised of a variety of modular structural accessory domains ([Figure 1](#f0010){ref-type="fig"}), most of which are currently of unknown function, but which are likely to play roles in protease activation, localization, and substrate recognition ([@bib12]).

The HAT/DESC Subfamily {#s0050}
----------------------

This subfamily is composed of 5 members in humans; HAT, DESC-1, HAT like-1 (HATL-1), HATL-4 and HATL-5, with mice having two additional members HATL-2 and HATL-3. This subfamily is the simplest of the TTSPs, having just one modular SEA-domain in their stem region. The role of this domain in HAT/DESC protease function has not been determined, but in other TTSPs such as matriptase, this domain undergoes a spontaneous conformation-induced auto-processing event at a conserved glycine residue which is important for protease activation ([@bib82], [@bib97]). As its name implies, HAT protease (also known as TMPRSS11D) is found predominantly expressed in the epithelium of the airways, where it was originally identified as a soluble form found in extracellular lung fluids of asthma patients ([@bib125], [@bib144], [@bib148]). The normal physiological function of HAT is unknown, and deletion of the gene in mice caused no phenotypical defects in development or long-term health under non-challenged conditions ([@bib108]). Pathologically, HAT is up-regulated in chronic airway diseases ([@bib144]), and has been shown *in vitro* to increase cell proliferation, and modulate inflammatory processes including increasing mucin production and suppression of fibrin deposition in airway epithelial cultures, suggesting it may play a role in disease suppression ([@bib80], [@bib85], [@bib150]). *In vitro*, HAT has been shown to cleave the urokinase plasminogen activator receptor (uPAR) ([@bib7]) and protease activated receptor (PAR)-2 ([@bib51]), although the *in vivo* relevance of these substrates remains to be demonstrated. Interestingly, HAT may play a role in the propagation and spread of human respiratory viruses. HAT has been shown to cleave and activate the influenza virus hemaglutinin (HA) glycoprotein ([@bib5], [@bib9]), and the severe acute respiratory syndrome (SARS) coronavirus spike protein ([@bib8]), both of which are important for mediating host cell entry, suggesting that inhibition of HAT activity may be a good target for therapeutic intervention in these infections.

Little is known regarding the *in vivo* function of the other members of this subfamily, which are expressed predominantly in epithelial cells of various organs. DESC-1 (also known as TMPRSS11E) is expressed in the epidermis, prostate, testis, placenta, thymus, and the epithelium of the head and neck ([@bib67], [@bib108], [@bib111]), where it was originally identified based on it\'s loss of expression in head and neck squamous cell carcinomas ([@bib108]). HATL-1 (also known as TMPRSS11A) is most highly expressed in the esophagus and trachea ([@bib27], [@bib54]), and like HAT, the HATL-1 null mouse shows no overt phenotype ([@bib108]). Similarly, this protease may mediate the spread of SARS-corona virus through cleavage of the viral host cell entry spike glycoprotein ([@bib54]). HATL-4 (also known as TMPRSS11F) mRNA is expressed in the esophagus and testis, with lower expression in the cervix, placenta, and trachea ([@bib108]). HATL-5 (also known as TMPRSS11B) displays a relatively restricted tissue expression profile, being expressed in the cervix, esophagus, and oral cavity, with lower expression in the kidney and testis ([@bib87], [@bib108]). This protease is found expressed in the more differentiated epithelial cells of cervix, esophagus, and trachea ([@bib87]), and is lost in squamous cell carcinomas of these tissues.

The Hepsin/TMPRSS Subfamily {#s0055}
---------------------------

This subfamily is composed of seven members in humans and mice. Hepsin possesses only one additional domain in its stem region, a group A scavenger receptor domain. TMPRSS2, TMPRSS3, TMPRSS4, mosaic serine protease large-form (MSPL), and spinesin have an additional low density lipoprotein receptor class A (LDLA) domain N-terminal to the scavenger domain, while enteropeptidase is much more complex containing multiple other domains types ([Figure 1](#f0010){ref-type="fig"}). Hepsin (also known as TMPRSS1), is abundantly expressed in the liver, but is also found at lower levels in other tissues such as the kidney, stomach, prostate, thyroid, and inner ear ([@bib35], [@bib66], [@bib131]). Physiological functions for hepsin have been identified in both liver and inner ear using murine models. While hepsin deficient mice do not show any strong defects in development or fertility ([@bib142]), mice lacking hepsin expression have abnormal cochlear structure and are deaf ([@bib35]). The physiological substrate cleaved by hepsin to mediate cochlear development has not been determined, but hepsin-deficient mice also show significantly reduced levels of the thyroid hormone thyroxine ([@bib35]) which is known to be important for cochlear development. Any relevance of hepsin expression to human hearing is yet to be reported. Recent analysis of liver specific hepsin null mice show its expression is important for maintenance of the structural integrity of the liver, with knock-out livers showing increased hepatocyte size and narrowed liver sinusoids ([@bib48]). These authors demonstrated that the likely *in vivo* substrate cleaved by hepsin to regulate liver physiology is pro-hepatocyte growth factor (pro-HGF), a growth factor shown to be a substrate of hepsin *in vitro* ([@bib59]). Of importance, treatment of liver specific hepsin null mice with the active form of HGF was able rescue these phenotypic defects ([@bib48]).

TMPRSS2 (also known as epitheliasin) is expressed in the epithelium of many tissues including the prostate, gastrointestinal tract, breast, lung, kidney, pancreas, ovary, lung, and salivary gland ([@bib27], [@bib53]). TMPRSS2 is of unknown function and is not required for normal development or health in mice ([@bib58]). Similar to HAT, TMPRSS2 may augment virus entry into airway epithelium increasing virus propagation by cleaving the HA protein of influenza A virus (IAV) ([@bib37], [@bib106]), and the SARS coronavirus spike protein ([@bib41]). Of note, TMPRSS2 deficient mice are highly resistant to experimental IAV virus challenges (H1N1, H3N2, and H7N9 strains), which is associated with reduced HA cleavage *in vivo,* suggesting TMPRSS2 is a key host protease important for IAV infection and may represent a new therapeutic target in humans ([@bib37], [@bib106]). TMPRSS3 (also known as TADG-12), is also expressed in epithelium of a variety of tissues where its function is unknown, however, its expression in the cochlea of the inner ear has been shown to be critically important for hearing in both humans and mice. At least five different point mutations in TMPRSS3 gene that affect protease activity have been linked to autosomal recessive deafness in humans (Guipponi *et al.,* 2008; [@bib68], [@bib110], [@bib136]). Furthermore, mice with TMPRSS3 deficiency are deaf, with reduced cochlear hair cell survival at the onset of hearing ([@bib28]). The identification of the substrate cleaved by TMPRSS3 to mediate hearing is unknown, but expression of hair cell KCNMA1 potassium channels is reduced in mice with mutated TMPRSS3 ([@bib89]), suggesting a role in the acquisition of mature ion channels during cochlear development. Little is known about the biological function of TMPRSS4, also known as CAP-2 for its ability to activate ENaCs *in vitro* ([@bib2], [@bib99]). However, it is over-expressed in a variety of epithelial carcinomas where it is correlated with disease progression and predicts poor patient survival (reviewed in [@bib22]). *In vitro* studies suggest TMPRSS4 mediates cancer cell invasion, epithelial--mesenchymal transition, and metastasis ([@bib49], [@bib57], [@bib88]), where TMPRSS4 proteolytic activation of urokinase plasminogen activator (uPA) may be involved ([@bib88]). TMPRSS5 (also known as spinesin), has an unusual expression pattern in comparison to other family members, being highly expressed in the brain and spinal cord ([@bib143]), where its function is unknown. TMPRSS5 is also expressed in the inner ear, and may be important for human hearing (Guipponi *et al.*, 2008). MSPL (also known as TMPRSS13) is expressed in the lung, placenta, prostate, and pancreas ([@bib56]) where its physiological function is unknown. Similar to HAT and TMPRSS2, it may play a role in influenza virus infection through cleavage of HA ([@bib98]). Enteropeptidase (commonly known as enterokinase, also known as PRSS7) is expressed in upper small intestine (duodenum and jejunum) on the brush border of enterocytes of the intestinal villus ([@bib40], [@bib61], [@bib60], [@bib153]). Enteropeptidase has long been known to play a critical role in human digestion by activating a proteolytic cascade that results in the activation of numerous proteases important for human digestion (reviewed in [@bib154]). Enteropeptidase cleaves and activates pancreatic trypsinogen to trypsin, which in turn activates other digestive zymogens such as chymotrypsinogen, proelastase, procarboxypeptidase, and prolipase in the lumen of the gut ([@bib65]). Mutations that lead to truncated forms of the protease that lack the active site are shown to cause malabsorbtion and failure to thrive in infants ([@bib42]).

The Matriptase Subfamily {#s0060}
------------------------

This TTSP subfamily has four members -- matriptase, matriptase-2, matriptase-3, and polyserase-1, which contain various combinations of accessory domains in their stem regions ([Figure 1](#f0010){ref-type="fig"}). Matriptase (also known as PRSS14, MT-SP1, CAP3, epithin, ST14) is the most well characterized of this subfamily and is found widely expressed in all epithelia ([@bib78], [@bib96]). Matriptase has been shown to be critical for epithelial barrier function using mouse models of matriptase deficiency ([@bib75], [@bib77]). In humans, mutations affecting matriptase\'s enzymatic activity present with a rare form of skin disease ([@bib6]; ARIH, see [Table 2](#t0015){ref-type="table"}), which is characterized by scaly, itchy skin with increased permeability, similar to the phenotype of matriptase null mice ([@bib75], [@bib74]). The substrate(s) cleaved by matriptase in the regulation of skin barrier function remain to be elucidated, although matriptase is thought to activate the pro-prostasin zymogen in this tissue ([@bib93]). In the polarized epithelium of the gastrointestinal tract where matriptase localizes to adherens junctions ([@bib14]), matriptase is also critically important for regulating intestinal epithelial barrier function ([@bib14], [@bib77]), and mice deficient in intestinal matriptase develop chronic inflammation and spontaneous colitis-induced colon adenocarcinoma ([@bib64]). In murine models, matriptase deficiency increases susceptibility to experimental colitis, and is found to be downregulated in human Crohns disease and ulcerative colitis ([@bib92]). The matriptase substrate that regulates intestinal barrier function is unknown, but matriptase has been reported to induce an intracellular atypical protein kinase C signaling pathway that regulates the composition of the apical tight junctions ([@bib14]). In the intestine and in contrast to the skin, prostasin appears to act upstream of matriptase and is important for inducing its activation in intestinal epithelium ([@bib13]). There is also the possibility of a reciprocal zymogen activation cascade between these two proteases in different tissues, suggesting that both matriptase and prostasin zymogens may act as cofactors that can induce the activation of each other, in a mechanism that is independent of catalytic activity ([@bib32]). Matriptase is also lost in the salivary gland of patients with Sjrogen\'s syndrome which exhibit salivary gland dysfunction and develop autoimmunity. Its loss may be important for disease pathogenesis, since matriptase deficiency in mice induces a primary Sjogren\'s syndrome-like phenotype with autoimmunity and loss of gland function ([@bib149]).

Matriptase also possesses strong oncogenic activities and in many epithelial cancers, its increased expression or activity (through loss of inhibition) is associated with disease progression (reviewed in [@bib73]). Low level over-expression of matriptase in murine skin is sufficient to induce multistage carcinogenesis and invasive squamous cell carcinoma ([@bib79]). Based on murine models, the mechanism by which matriptase induces squamous cell carcinoma involves cleavage and activation of the matriptase substrate pro-HGF ([@bib70], [@bib122]). *In vitro* studies also identified matriptase as the first membrane-anchored serine protease to activate the G-protein coupled receptor, PAR-2 ([@bib17], [@bib126]). *In vivo* evidence suggests that cleavage of PAR-2, which induces inflammatory signaling pathways, may be an essential component for matriptase induced malignant progression of squamous cell carcinomas in animal models ([@bib107]). Matriptase activity in the skin also has been linked to the initiation of Netherton syndrome, which results from a loss of function mutation in the serine protease inhibitor LEKTI, which is important for regulating the activity of kallikrein proteases in the skin ([@bib109]). Genetic ablation of matriptase in mice deficient in the LEKTI inhibitor reduced inflammation, reduced aberrant protease activity and improved barrier function in the skin, suggesting matriptase is pathologically important in the human disease through kallikrein activation ([@bib109]).

Matriptase-2 (also known as TMPRSS6) is most highly expressed in the liver, but is also found in the kidney and uterine tissue ([@bib44], [@bib133]). Matriptase-2 has a significant function in the regulation of iron metabolism. Humans with point mutations that effect matriptase-2 activity suffer from iron-refractory iron deficient anemia ([@bib29], [@bib33], [@bib86]), manifested by very low iron levels and severe microcytic anemia. Mice deficient in matriptase-2 expression also show this iron deficient phenotype ([@bib26], [@bib129]). Matripase-2 is thought to function by suppressing the expression of the liver hormone hepcidin which is known to be an important mediator of iron uptake by liver cells. This suppression occurs indirectly at the mRNA level, and is thought to be mediated by matriptase-2 cleavage of the bone morphogenetic protein (BMP) co-receptor hemojuvelin ([@bib115], [@bib114], [@bib129]), which has a role in activation of hepcidin transcription. Matriptase-3 (also known as TMPRSS7) is expressed in the brain, skin, salivary gland, and reproductive tissues ([@bib121]); however, its physiological functions remain to be determined. Polyserase-1 (also known as TMPRSS9 and serase1B) is expressed in skeletal muscle, heart, kidney, liver, placenta, and brain ([@bib16], [@bib15]). This TTSP is highly unique in that it possesses 3 SPDs but its function is currently unknown.

The Corin Subfamily {#s0065}
-------------------

Corin (also known as TMPRSS10) is the only member of this subfamily, and is unique in that it possesses two frizzled-like cysteine rich domains in its stem region, along with multiple LDLA domains and a scavenger domain ([Figure 1](#f0010){ref-type="fig"}). Corin is highly expressed in cardiomyocytes of the heart, but also in kidney, bone, brain, skin, and pregnant uterus ([@bib47], [@bib146]). Corin plays an important role in maintaining heart function and decreasing blood volume and blood pressure, by processing the cardiac hormone pro-atrial natriuretic peptide (pro-ANP) ([@bib140], [@bib147]). Corin cleaves and activates pro-ANP to mature ANP which promotes natriuresis, diuresis, and vasodilation. In humans, mutations in the corin gene which result in reduced activation and protease activity have been reported in patients with hypertension and cardiac hypertrophy, and are associated with a poorer prognosis in patients with heart failure ([@bib25], [@bib102], [@bib103], [@bib135]). Corin-deficient mice spontaneously develop salt-sensitive hypertension, cardiac hypertrophy and increased body weight, and possess an elevated level of pro-ANP and an absence of active ANP ([@bib20], [@bib95]). Corin and ANP have also been shown to be important for promoting placental trophoblast invasion and spiral artery remodeling in the pregnant uterus ([@bib23]). Pregnancy in corin- or ANP-deficient mice results in the development of high blood pressure and proteinuria, which are characteristics of pre-eclampsia. Interestingly, in human pre-eclamptic patients, uterine corin expression was found to be reduced, and several corin mutations which cause proteolytic activity were also identified in pre-eclamptic patients, suggesting defective corin may be pathologically important in this disease.

Conclusion {#s0070}
==========

Following the sequencing of the human genome at the turn of the century and the discovery of the family of membrane-anchored serine proteases, these enzymes have emerged to play key roles in many diverse aspects of mammalian physiology. The misregulation of these enzymes is emerging to contribute to the pathology of a variety of diseases. The plasma membrane is a dynamic, fluid microenvironment where cell surface molecules act as cell sensors, initiating signals and relaying information. The extracellular SPDs contained in these molecules likely target specific cellular substrates, growth factors, receptors, and components of the extracellular matrix to modulate irreversible changes in the cellular environment. Clearly these unique enzymes represent potential strategic targets for diagnostic and therapeutic applications for a wide range of diseases.

See also {#s0075}
========
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